CD160 and cutaneous leishmaniasis: Consequently, the expression of PD-1, CTLA-4, 2B4, CD160, and TIM-3 was evaluated ex vivo in PBMCs from 10 HD, 4 asymptomatic subjects, 5 patients cured of cutaneous leishmaniasis and 4 patients with active CL.